%0 Journal Article
%T Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
%A Noy Ariela
%A Kaplan Lawrence
%A Lee Jeannette
%A Cesarman Ethel
%J Infectious Agents and Cancer
%D 2012
%I BioMed Central
%R 10.1186/1750-9378-7-s1-o14
%U http://www.capconcorp.com/meeting/2011/13thICMAOI/index.asp